Fingerprint
Dive into the research topics of 'Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
Paul Richardson, Constantine Mitsiades, Kathleen Colson, Eileen Reilly, Laura McBride, Judy Chiao, Linda Sun, Justin Ricker, Syed Rizvi, Carol Oerth, Barbara Atkins, Ivy Fearen, Kenneth Anderson, David Siegel
Research output: Contribution to journal › Article › peer-review
177
Scopus
citations